Back to Top Skip to main content Skip to sub-navigation

Former BAMC COVID-19 patient now CCP donor

Man donating blood Former Brooke Army Medical Center COVID-19 patient Thefety Tibbs donates COVID-19 convalescent plasma at the Akeroyd Blood Donor Center at the Brooke Army Medical Center in San Antonio, Texas. (Photo by Mark Salcedo, Akeroyd Blood Donor Center at Brooke Army Medical Center.)

Recommended Content:

Coronavirus | Convalescent Plasma Collection Program | Armed Services Blood Program

The COVID-19 Convalescent Plasma (CCP) Collection Program is a Department of Defense effort to obtain 10,000 units CCP with emphasis on blood donations by members of the military community who have recovered from the disease. CCP will be given to critically ill patients, and to support the development of an effective treatment against the disease. Potential donors should visit the Armed Services Blood Program website to find a complete list of available collection centers.

Thefety Tibbs was one of the first COVID-19 patients treated at Brooke Army Medical Center aboard Joint Base San Antonio-Fort Sam Houston.

Now he’s back at the military medical treatment facility as one of the first former patients to donate convalescent plasma, which is currently being explored as a potential treatment for COVID-19.

Tibbs explained that on the evening of April 10, he wasn’t feeling well. He had already taken medicine for a headache, but decided to go to the emergency room due to relentless sinus pressure. After receiving x-rays and an initial diagnosis of pneumonia, the staff completed a swab culture. Shortly after, he was informed that he had tested positive for COVID-19. He was quickly moved to a COVID-19-specific ward.

“It was a challenge from then on,” Tibbs said. “I really didn’t know what to expect. You see it on the news and you see people dying. And then they took care of me. I was worried that first night, but they took care of me all the way through.”

He made a full recovery and was released 10 days after he had been admitted. Then about two weeks later he received a request to donate convalescent plasma. After some internal debate, he decided to accept the request. 

When someone contracts a virus, that person’s immune system creates antibodies to fight the virus. For people who successfully fight a virus, their plasma will now contain infection-fighting antibodies called “convalescent plasma.” For this virus the plasma is referred to as COVID-19 convalescent plasma, or CCP. Patients who have fully recovered from the COVID-19 disease can donate their plasma as a potential treatment for others who are fighting the same disease.

Anyone who chooses to donate convalescent plasma goes through the same Armed Services Blood Program (ASBP) process as someone who donates regular plasma; but there are some extra requirements for donors to be eligible to donate convalescent plasma. Donors must be at least 17 years old, weigh at least 116 lbs. and be in good general health. Additionally, to donate convalescent plasma, volunteers must have already had COVID-19 and be fully recovered for at least 14 days. This means donors must be symptom-free for the full two weeks before they will be considered for donation and all donations are screened for COVID-19 antibodies.

“All potential CCP donors must be prescreened before I can set them up for an appointment,” said Mark Salcedo, the blood donor recruiter for the JBSA Fort Sam Houston ASBP. “If the donor is prescreen eligible, I'll forward to our medical director for his review.  He reviews their medical history and either approves or disapproves their donation. Once approved, I can schedule them for a plasma appointment. The staff does a lot on the front end of a CCP donation to protect the donor's health and the safety of the military's blood supply.”

There are two ways eligible donors can give convalescent plasma. The first is by donating whole blood. This yields one dose of convalescent plasma. The process takes about 15 minutes and donors can return to donate every 56 days. The second is by donating plasma which yields about three to four doses of convalescent plasma, but takes about 45 minutes. For their safety, staff at the Akeroyd Blood Donor Center require a minimum of 28 days between convalescent plasma donations.

“I wanted to try and help somebody else who has the virus,” Tibbs said about his decision to donate. “It was very efficient so I decided to keep on going in. The team is excellent. They made me feel very comfortable.”

BAMC and other military medical treatment facilities continue to seek donations of convalescent plasma from eligible donors.

Salcedo said there are currently about 150 donors in their system, but they are still looking for more. Anyone in the San Antonio area who is interested, and eligible, can donate at the Akeroyd Blood Donor Center on JBSA Fort Sam Houston. Interested donors can contact Mark Salcedo at 210-295-4655 or 210-295-4109.  For the full list of all donor centers and to learn more, check out the Armed Services Blood Program at: https://militaryblood.dod.mil/.

You also may be interested in...

DHA-PI 6205.01: Medical Logistics Guidance for the DoD Coronavirus Disease 2019 (COVID-19) Vaccination Program

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (n), establishes the Defense Health Agency's (DHA's) procedures for ordering, receiving, and managing COVID-19 Vaccines inventory and ancillary kits.

DHA-IPM 20-004: Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

Policy

This Defense Health Agency (DHA) Interim Procedures Memorandum (IPM), based on the authority of References (a) through (d), and in accordance with the guidance cited in References (e) through (aa), establishes the DHA’s procedures to implement instructions, assign responsibilities, and prescribe procedures for the COVID-19 Vaccination Program. This DHA-IPM applies to DHA, DHA Components (activities under the authority direction, and control of the DHA), Military Departments (MILDEP), and the United States Coast Guard (CG). This DHA-IPM cancels and replaces DHA-IPM 20-004, “Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation,” December 13, 2020.

TAB A MEO COVID19 Medical Coding Policy

Policy

Memorandum for DHA Staff - Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

  • Identification #: N/A
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

DHA COVID19 Medical Coding PolicyV5 1v

Policy

Establishes the DHA procedures to standardize the coding for Coronavirus 2019 (COVID-19) within military medical treatment facilities (MTFs). This memorandum replaces DHA-Policy Memorandum 20-003 of July 1, 2020. Attachment 1 was updated to include the 2021 procedure and diagnosis codes for COVID-19, including the new vaccination and treatment codes.

  • Identification #: 20-003
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

Supplemental Guidance for Providing DoD Coronavirus Disease 2019 Vaccines to DoD Contractor Employees and Select Foreign Nationals

Policy

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components as appropriate.

HA Guidance for Coronavirus Disease 2019 (COVID-19) Laboratory Pre-Testing Questionnaire

Policy

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DoD beneficiaries treated at military medical treatment facilities.

Executive Order on Ensuring Access to United States Government COVID-19 Vaccines

Policy

This EO outlines who should receive priority access to COVID-19 vaccines developed in the United States or procured by the United States Government (“United States Government COVID-19 Vaccines”).

Coronavirus Disease 2019 Vaccine Guidance

Policy

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components.

DHA-AI 3020-01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), based on the authority of References (a) through (b) and in accordance with the guidance of References (c) through (z3), establishes the Defense Health Agency's (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic. This DHA-AI also provides a preventive plan to monitor and assess for the appearance of new cases and implement those processes that will prevent them from impacting the workforce. The processes describe herein are intended to offer an actionable plan for the workforce to re-enter DHA Administrative Offices. See Appendix 1 for a summary of the DHA Administrative Office Reopening Plan. The plan uses the Force Health Protection Guidance and Health Protection Conditions (HPCON), in accordance with Reference (d), to ensure protection for the workforce, including the most vulnerable-to-serious complications from the virus while enabling DHA Administrative Offices to continue its mission. See Appendix 2 for the conceptual HPCON framework.

  • Identification #: 3020-01
  • Date: 11/3/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

DHA AI 3020.01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 (COVID-19) Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), establishes the Defense Health Agency’s (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic and in preparation for regression or resurgence in COVID-19 cases that could impact the workforce.

  • Identification #: DHA AI 3020.01
  • Date: 6/12/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

Guidance Regarding Zika Dengue and Chikungunya Viruses

Policy

This guidance contains information about the potential for transfusion-transmitted Zika infection; recommends facilitating donor self-deferral of 28 days after travel to Mexico, the Caribbean, Central America and South America.

DoD Directive 6000.12E: Health Service Support

Policy

This directive designates the Secretary of the Army as the DoD Executive Agent for the Armed Services Blood Program Office (ASBPO) (Reference (h)), who exercises this authority through the Surgeon General of the Army, in accordance with DoDD 5101.1 (Reference (d)).

DoD Instruction 6480.04: Armed Services Blood Program Operational Procedures

Policy

This instruction assign responsibilities, and prescribe procedures to carry out the responsibilities of the Armed Services Blood Program (ASBP) during peacetime, contingency, and wartime operations.

Showing results 1 - 13 Page 1 of 1

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.